Regenerative care for urology practices.
Focused shockwave, PRP, and vetted biologics for erectile dysfunction, Peyronie's disease, and chronic pelvic pain — with clinic-ready protocols.
Urology was one of the earliest adopters of low-intensity extracorporeal shockwave therapy for vasculogenic ED, and the evidence base has since expanded to Peyronie's disease and chronic pelvic pain syndromes. DRS partners with urology practices on device selection, protocol design, staff training, and biologics sourcing.
Common indications we support
- Vasculogenic erectile dysfunction
- Peyronie's disease (acute and chronic phases)
- Chronic pelvic pain syndrome (CPPS)
- Post-prostatectomy erectile rehabilitation
- Chronic prostatitis (category III)
- Stress urinary incontinence adjunct care
Devices, biologics & protocols for this specialty
Low-intensity focused shockwave platforms with urology-specific transducers and treatment templates.
Device optionsSession count, energy flux density, and follow-up assessment templates for ED, Peyronie's, and CPPS.
Read the protocolsOperational playbook — training time, ROI modeling, and staffing for a new ECSWT service line.
Practice guideAutologous PRP prep pathways used adjunctively in Peyronie's and sexual medicine.
PRP biologicsPublications relevant to this specialty
Curated evidence from our Publications library that references Regenerative care for urology practices.
Bring regenerative medicine into your practice.
Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.